Navigation Links
Weight-Loss Surgery Helps Less Obese Patients: Study
Date:6/16/2011

By Alan Mozes
HealthDay Reporter

THURSDAY, June 16 (HealthDay News) -- Obese patients whose body-mass index (BMI) falls below the minimum level recommended for weight-loss surgery may have better outcomes than those who are more obese, new research suggests.

An analysis of data from nearly 1,000 patients revealed that those patients whose pre-surgery BMIs were below the federal guideline threshold of 35-plus experienced a 100 percent remission from type 2 diabetes in the year following surgery.

In contrast, the remission rate for type 2 diabetes in obese patients with a BMI of 35 or more was about 75 percent.

"There was a clear trend that as your weight was lower when having gastric bypass surgery, your outcomes were actually better," noted study co-author Dr. John Morton, director of bariatric surgery at Stanford Hospital & Clinics at Stanford University in Palo Alto.

"This finding suggests that perhaps we should be getting patients to surgery sooner than later, before their weight goes too high and the surgery comes less effective," Morton said.

"After all, when we talk about patients below a BMI of 35, we're not talking about people who are just pleasantly plump," Morton added. "These are people with real, substantial risks associated with excess weight, particularly with respect to diabetes, which has a lot of negative consequences."

Morton and his colleagues are slated to present their findings Thursday at the American Society for Metabolic & Bariatric Surgery annual meeting, in Orlando, Fla. Because the study has not been published in a peer-reviewed journal, its findings should be viewed as preliminary.

Guidelines from the National Institutes of Health recommend gastric bypass only for patients whose BMI is 35 or more and who have an obesity-related condition (such as high blood pressure, sleep apnea, joint disease and/or metabolic syndrome) and who have not been able to lose weight through less invasive methods.

For someone with a BMI of 40 or more, an obesity-related disease is not necessary to qualify for weight-loss surgery, according to NIH guidelines.

Morton noted that ideally one's BMI should clock in under 25. For a woman with a height of 5-foot-4, this would roughly equate to weighing about 140 pounds.

A woman of the same height who weighs 200 pounds would actually fall just short of the BMI threshold of 35, he said, while at 300 pounds the same woman would have a BMI of nearly 52.

Morton explained that the current study came about almost accidentally, as a result of a Stanford pre-surgical program designed to educate prospective patients about the surgery and to encourage them to adopt better nutritional habits before the operation.

Out of the 980 obese patients who had met the NIH criteria when they were initially slated for surgery between 2004 and 2010, 12 patients actually showed up for the procedure at BMI levels below the recommended cut-off point for surgery.

The result: a year following surgery, those patients with a BMI under 35 not only experienced better outcomes in terms of diabetes, but lost more weight than those who met the recommended BMI threshold for weight-loss surgery. They also showed more improvement in obesity-related conditions in addition to diabetes.

At check-ins from three-months to a year after surgery, the patients who weighed less than that recommended for gastric bypass had also lost more weight than those with the higher BMIs. At the 12-month mark, they had lost 167 percent of their excess weight, in contrast to those with a BMI of 35 to 40 (112 percent), 40 to 45 (85.3 percent), and 50 (67 percent).

The authors also noted that the time it took to perform the gastric bypass procedure itself was also shorter for those with lower BMIs.

"What we found amounts to what I think is a big lesson: we ought to intervene with these patients earlier than previously thought," said Morton.

Like all operations, weight-loss surgery is not without risk. Complications include serious infections, internal bleeding and blood clots, and the risk of dying is one in 1,000, according to the American Society for Metabolic & Bariatric Surgery.

Weight-loss surgeries are also expensive, costing about $20,000 to $25,000 or more, depending on the procedure.

Dr. David M. Kendall, chief scientific and medical officer of the American Diabetes Association, approached the findings with some caution.

"While these are exciting and interesting findings, it is really the first set of evidence that looks at this specifically," he said. "We need more research with larger groups and for longer periods of follow-up before we can really start ringing the bell."

"More generally, the other thing I would add is that while bariatric surgery has on several occasions shown impressive results across various bands of weight, people need to be reminded that even modest weight loss and improved glucose control in the absence of surgery can help immensely in terms of diabetes control" and prevention, Kendall said.

More information

For more on bariatric surgery, visit the National Institutes of Health.

SOURCES: John Morton, M.D., associate professor, surgery, and director, bariatric surgery, Stanford Hospital & Clinics, Stanford University, Palo Alto, Calif.; David M. Kendall, M.D., chief scientific medical officer, American Diabetes Association, Washington D.C.; June 16, 2011, presentation, American Society for Metabolic & Bariatric Surgery annual meeting, Orlando, Fla.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Can Weight-Loss Surgery Reverse Common Cause of Infertility?
2. Rushed Discharge After Weight-Loss Surgery May Raise Risks
3. Weight-Loss Surgery Can Be Effective Despite Depression
4. For Many, Weight-Loss Surgery Also Eases Migraines
5. Surgically shrinking the stomach when conservative weight-loss treatments fail
6. Weight-Loss Surgery May Lower Risk of Alzheimers in Diabetics
7. Weight-Loss Surgery Linked to Rise in Fracture Risk
8. Private weight-loss surgery clinics shedding quality patient care
9. Weight-Loss Surgery Seems No Riskier for Seniors
10. Weight-loss counseling most prevalent between male physicians and obese men
11. Experimental Weight-Loss Drug Seems to Work: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weight-Loss Surgery Helps Less Obese Patients: Study
(Date:1/16/2017)... ... ... Louisans are well-aware of the following facts at present:, Flu ... having no effect on keeping this particularly bad strain of the flu away , ... or sniffling , These facts are well-known among the team at Woodard! ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... San Francisco ... iTero Element, the latest in 3-D scanning device which is capable of taking digital ... latest advances in dentistry, such as CAD CAM restorations , in terms of ...
(Date:1/15/2017)... Cary, NC (PRWEB) , ... January 15, 2017 , ... Whole Health Supply, LLC is ... CP-140L . There are also new avenues for purchase. , The 2017 edition has ... can cause issues for the older boomers as well as diabetics. This handle is reinforced ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor ... Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing gym, the ... sixth location, including three in New Jersey and two in New York. With this ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition ... in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... freeze frame transition from one clip to the next. , To use “Cut-Out ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... Jan. 14, 2017  Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... According ...
(Date:1/13/2017)... -- Eli Lilly and Company (NYSE: LLY ... announced today that the U.S. Food and Drug Administration ... drug application (NDA) for investigational baricitinib, a once-daily oral ... arthritis (RA). The NDA for baricitinib was submitted to ... extended the action date to allow time to review ...
(Date:1/13/2017)... York , January 13, 2017 ... prevalence of AIDS will collectively contribute to the demand for ... to reach a value of US$ 551.0 Mn by 2016 ... will remain the most lucrative markets for western blotting, whereas ... the market globally. ...
Breaking Medicine Technology: